In cardiovascular disease, PP2A activity is involved in a wide variety of pathophysiological processes, such as arrhythmia, cardiac remodeling, vascular remodeling, oxidative stress, ischemia-reperfusion injury, and endothelial dysfunction (16–20). This evidence concerns the gene PTPA and cardiovascular disorder.